Talks and Q&A with Benedikt Holbling and Prof James Rowe on frontotemporal dementia and the latest research.
FTD is caused by damage to cells in areas of the brain called the frontal and temporal lobes. These areas of our brains control our personality, emotions and behaviour, as well our speech and understanding of words.
Benedikt’s research looks into the cellular and molecular mechanisms that can cause frontotemporal dementia. In his fascinating talk, he discussed how he uses stem cells to study this.
Prof James Rowe talked about the current and upcoming trials taking place in frontotemporal dementia. He hopes that these collaborative efforts will change the field of research, and that new treatments are within reach.
Prof James Rowe is a Professor of Cognitive Neurology at the University of Cambridge and a practicing consultant neurologist. He is also Chair of our Strategic Advisory Board.
James leads regional specialist clinics for rare dementias and is a consultant at Cambridge Memory Clinic. He balances his clinical work with leading a team of researchers studying FTD and related diseases, with the aim of understanding the underlying characteristics, improving diagnoses, and informing new treatments.
Find out more about James.
Benedikt Hölbling is a PhD student working at the UK Dementia Research Institute at University College London. His work examines the mechanisms of motor neurone disease (MND) and frontotemporal dementia, using stem cells.
Before his PhD, Benedikt studied Molecular Biomedicine, and also completed a Masters degree in Cellular and Molecular Neuroscience, focusing on neurodegeneration.